Wealthsource Partners, LLC Neu Base Therapeutics, Inc. Transaction History

Wealthsource Partners, LLC

  • $1.52 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$0.18 - $0.3 $63 - $105
-350 Reduced 2.44%
14,000 $2,000
Q2 2022

Aug 10, 2022
SELL
$0.82 - $1.93 $7,789 - $18,335
-9,500 Reduced 39.83%
14,350 $15,000
Q1 2022

May 09, 2022
BUY
$1.26 - $2.95 $30,051 - $70,357
23,850 New
23,850 $45,000

About NeuBase Therapeutics, Inc.

NBSE Quotes by TradingView
  • Ticker NBSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,258,700
  • Description
  • NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...
More about NBSE
Track This Portfolio

Track Wealthsource Partners, LLC Portfolio

Follow Wealthsource Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthsource Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email